SynthesisFrontiers in pharmacology2026
Systematic review and network meta-analysis of integrated traditional Chinese and conventional medicine for ulcerative colitis.
Synthesis in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To optimize clinical management of ulcerative colitis (UC) and evaluate the efficacy of traditional Chinese medicine (TCM), conventional medicine (CM), and integrated TCM- CM therapies. Methods: Randomized controlled trials (RCTs) investigating integrated TCM-CM treatment for UC were retrieved from PubMed, Embase, Web of Science, CNKI, Wanfang Data, VIP Database, and SinoMed from database inception to June 2025. Study quality was assessed using Review Manager 5.4 and the 7-point Jadad scale. Statistical analyses were performed using Stata MP 15 and R 4.3.1 with Rstudio. Results: A total of 46 RCTs involving 3,763 patients with UC were included, comprising seven intervention regimens: four commercial Chinese polyherbal preparation (e.g., Yunnan Baiyao) and sixteen classical TCM decoctions (TCMDs; e.g., Baitouweng Decoction). The results showed that conventional medicine combined with TCMD and acupoint catgut embedding achieved the highest total effective rate. CM alone ranked highest in alleviating key clinical symptoms (e.g., diarrhea and abdominal pain) and in reducing inflammatory markers, including IL-8, C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR). For cytokine regulation, comparative advantages varied across interventions: CM + TCMD + acupuncture ranked highest for IL-6 reduction, CM + TCMD ranked highest for IL-10 improvement, whereas CM alone ranked lower for these two outcomes. Conclusion: Compared with the single use of conventinal medicine, the combined use of traditional Chinese and conventinal medicine in the treatment of ulcerative colitis demonstrates greater overall efficacy. Through network meta-analysis, this study identified optimal intervention regimens for different outcome indicators, including both monotherapy and combination therapy. In clinical practice, the optimal regimens may be selected according to individual patient conditions. Although TCM interventions can improve clinical symptoms and inflammatory biomarkers in patients with ulcerative colitis, relevant clinical score improvement and endoscopic mucosal healing evidence are still insufficient. Further high-quality clinical evidence is still required to confirm the definite clinical efficacy of TCM. Systematic Review Registration: https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=1109183, identifier CRD420251109183.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.